NORMAN, Okla. —
“Harold Hamm’s gift to augment the COBRE grant creates a unique public and private partnership to address the diabetes health crisis,” Boren said. “We are grateful for his continued leadership and tenacity in fighting the disease.”
This grant is a renewal of a $12 million grant awarded to the center in 2006, resulting in almost $23 million in total funding from this single grant program.
“The COBRE grant represents a remarkable return on investment,” said Blake Rambo, chief operating officer at the Harold Hamm Diabetes Center. “All five of the junior investigators who had projects funded by the 2006 COBRE were able to successfully attract new, independent grant funding for diabetes research at the center.
“Three junior investigators successfully obtained competitive R01 grant funding as a result of their studies under the COBRE, and two obtained grants from the American Diabetes Association and the American Heart Association.”
“The new COBRE funding will enable our researchers to focus on diabetes-related cardiovascular disease (Kenneth Humphries, Ph.D), vascular damage (Jian Xu, Ph.D), vision loss (Yun Le, Ph.D) and tissue damage (Franklin Hays, Ph.D),” said Jian-Xing Ma, Ph.D, laureate chair and professor of medicine, who serves as principal investigator of the COBRE grant. “Our investigators made many significant advances with the first round of COBRE funding, and the award of this renewal funding will allow them to build on those successes to make a meaningful impact on diabetes research.”
“These investigators represent the best of what’s to come in diabetes research, and to have them right here at the Harold Hamm Diabetes Center in Oklahoma, where they can have the greatest impact combating diabetes, is significant,” said Dr. Timothy Lyons, Chickasaw Nation chair in Diabetes Research and director of research and scientific affairs at the Harold Hamm Diabetes Center and an associate director and mentor on the COBRE grant.